deferoxamine has been researched along with HIV Coinfection in 6 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgna-Pignatti, C | 1 |
| Rugolotto, S | 1 |
| De Stefano, P | 1 |
| Zhao, H | 1 |
| Cappellini, MD | 1 |
| Del Vecchio, GC | 1 |
| Romeo, MA | 1 |
| Forni, GL | 1 |
| Gamberini, MR | 1 |
| Ghilardi, R | 1 |
| Piga, A | 1 |
| Cnaan, A | 1 |
| Costagliola, DG | 1 |
| de Montalembert, M | 2 |
| Lefrère, JJ | 1 |
| Briand, C | 1 |
| Rebulla, P | 2 |
| Baruchel, S | 1 |
| Dessi, C | 2 |
| Fondu, P | 1 |
| Karagiorga, M | 2 |
| Perrimond, H | 1 |
| Boelaert, JR | 1 |
| Weinberg, GA | 1 |
| Weinberg, ED | 1 |
| Salhi, Y | 1 |
| Costagliola, D | 1 |
| Lena-Russo, D | 1 |
| Girot, R | 1 |
| Prati, D | 1 |
| Davies, SC | 1 |
| Wonke, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Iron-mediated Vascular Disease in Sickle Cell Disease.[NCT01239901] | 150 participants (Actual) | Observational | 2009-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for deferoxamine and HIV Coinfection
| Article | Year |
|---|---|
Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management.
Topics: AIDS-Related Opportunistic Infections; Chelating Agents; Deferoxamine; Hemosiderosis; HIV Infections | 1996 |
Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major.
Topics: Anemia, Hemolytic; beta-Thalassemia; Blood Group Incompatibility; Blood Transfusion; Cardiovascular | 2000 |
The management of haemoglobinopathies.
Topics: Adolescent; Anemia, Sickle Cell; Bone Marrow Transplantation; Chelation Therapy; Child; Child, Presc | 1991 |
3 other studies available for deferoxamine and HIV Coinfection
| Article | Year |
|---|---|
Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
Topics: Adult; Age Factors; Arrhythmias, Cardiac; Blood Transfusion; Chelation Therapy; Cohort Studies; Defe | 2004 |
Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients.
Topics: Acquired Immunodeficiency Syndrome; beta-Thalassemia; Child; Deferoxamine; Disease Progression; Fema | 1994 |
Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients.
Topics: Child; Cohort Studies; Confounding Factors, Epidemiologic; Deferoxamine; Disease Progression; Dose-R | 1998 |